HuGE Literature Finder
Records
1
-
30
| The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection. Biomedical reports 2022 1 16 (2): 9. Matsumoto Kosuke, Miyaaki Hisamitsu, Fukushima Masanori, Sasaki Ryu, Haraguchi Masafumi, Miuma Satoshi, Nakao Kazuhi |
| Possible relationship between IL28B rs12979860 and TLR2 -196 to -174 del/ins polymorphisms and the liver fibrosis stage in hepatitis C patients. Archives of virology 2021 Nov . Öksüz Zehra, Üçbilek Enver, Serin Mehmet Sami, Yara? Serkan, Temel Gülhan Örekici, Sezgin Orh |
| IL28B rs12979860 polymorphism and zinc supplementation affect treatment outcome and liver fibrosis after direct-acting antiviral hepatitis C therapy. Journal, genetic engineering & biotechnology 2021 Oct 19 (1): 150. Attallah Abdelfattah M, Omran Dalia, Abdelrazek Mohamed A, Hassany Mohamed, Saif Sameh, Farid Aza, El Essawey Riham, Ghaffar Muhammad Abdel, Aabdelghany Marwa, Yosry Aym |
| [Investigation of the Relationship Between IL28B Polymorphisms and Plasma IL28B Levels in Patients with Chronic Hepatitis B or C]. Mikrobiyoloji bulteni 2021 Jul 55 (3): 374-388. Koç Kuralay Zeynep, Tu? Esra, Fidan I? |
| Correlation between IL-28 polymorphism and spontaneous clearance in HCV patients: systematic review and meta-analysis. Archives of virology 2021 Jul . Miri Hamid Heidarian, Fazeli Pooria, Ali-Hassanzadeh Mohammad, Bemani Peyman, Kabelitz Dieter, Kalantar Kuro |
| IL28B, TLR7 SNPs, and cytomegalovirus infection are risk factors for advanced liver disease in chronic hepatitis C patients. Expert review of anti-infective therapy 2021 May . Khalil Fatma Omar, Alsebaey Ayman, Kasemy Zeinab Abdelaziz, Abdelmageed Sabry Moawad, Bedair Hanan Mosaad, Abdelsattar Shim |
| Association between interleukin 28B polymorphism and sustained virological response to sofosbuvir plus daclatasvir in chronic hepatitis C genotype 4 Egyptian patients. Journal of clinical pharmacy and therapeutics 2021 Mar . Hassanien Khalid S, El-Sayed El-Sayed M, Ismail Raed S, Zakarya Zakarya M, Helal Gouda |
| Functional genetic variants of the IFN-?3 (IL28B) gene and transcription factor interactions on its promoter. Cytokine 2021 155491. Roy Subhajit, Guha Roy Debarati, Bhushan Anand, Bharatiya Seema, Chinnaswamy Sreedh |
| Pegylated interferon and ribavirin gone but not forgotten in the era of direct-acting antivirals. Minerva pediatrics 2021 1 74 (1): 23-30. Pluta Magdalena, Pokorska-?piewak Maria, Aniszewska Ma?gorzata, Lewandowski Zbigniew, Kowalik-Miko?ajewska Barbara, Marczy?ska Magdale |
| PNPLA3 polymorphisms are associated with raised alanine aminotransferase levels in hepatitis C virus genotype 3. Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 2020 Oct . Agrawal Tanvi, Gaggar Anuj, Subramanian Mani, Kottilil Shyam, Choudhary Abhijit, Rao Padaki N, Shah Sameer, Trehanpati Nirup |
| Impact of IL28B gene polymorphism on efficacy and safety of direct acting antivirals in hepatitis C Egyptian patients. International journal of clinical pharmacy 2020 Jul . Ebid Abdel-Hameed Ibrahim Mohamed, Ahmed Ossama Ashraf, Agwa Sara Hassan, Abdel-Motaleb Sara Mohamed, Hagag Radwa Sam |
| Association between IL28B Polymorphisms and Outcomes of Hepatitis B Virus Infection: A meta-analysis. BMC medical genetics 2020 May 21 (1): 88. Zhao Jingyu, Zhang Xinyue, Fang Liwei, Pan Hong, Shi J |
| Interleukin 28 Polymorphisms and Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy for Chronic Hepatitis C. Journal of gastrointestinal and liver diseases : JGLD 2019 Dec 28 (4): 449-456. Simili Angelo, Mazzella Giuseppe, Ravaioli Federico, Festi Davide, Bacchi-Reggiani Maria Letizia, Porro Alberto, Bazzoli Franco, Azzaroli Frances |
| Viral and host factors are associated with retreatment failure in hepatitis C patients receiving all-oral direct antiviral therapy. Hepatology research : the official journal of the Japan Society of Hepatology 2019 Dec . Mawatari Seiichi, Oda Kohei, Kumagai Kotaro, Tabu Kazuaki, Ijuin Sho, Fujisaki Kunio, Inada Yukiko, Uto Hirofumi, Saisyoji Akiko, Hiramine Yasunari, Hori Takeshi, Taniyama Ohki, Toyodome Ai, Sakae Haruka, Hashiguchi Masafumi, Kure Takeshi, Sakurai Kazuhiro, Tamai Tsutomu, Moriuchi Akihiro, Ido Ak |
| Correlation between interleukin-28 gene polymorphism with interleukin-28 cytokine levels and viral genotypes among HCV patients in Yazd, Iran. BMC research notes 2019 Sep 12 (1): 626. Moghimi Mansour, Tavakoli Forough, Doosti Masoud, Ahmadi-Vasmehjani Abbas, Akhondi-Meybodi Mohs |
| The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis. Medicine 2019 Sep 98 (38): e17275. Qin Shaoyou, Wang Jiangbin, Zhou Changyu, Xu Yan, Zhang Yonggui, Wang Xu, Wang So |
| The impact of IFNL3 genotype on interferon treatment outcome in patients chronically infected with hepatitis B virus: A meta-analysis. Microbial pathogenesis 2019 Jun 103598. Zhao Zhongyi, Qin Zhen, Zhou Linlin, Xiang Li, You Jiangzhou, Cao Ranran, Wang Hongren, Wang Baoning, Li Mingyu |
| IL28B gene polymorphism is correlated with changes in low-density lipoprotein cholesterol levels after clearance of hepatitis C virus using direct-acting antiviral treatment. Journal of gastroenterology and hepatology 2019 May . Morihara Daisuke, Ko Yi-Ling, Shibata Kumiko, Yamauchi Ryo, Fukuda Hiromi, Tsuchiya Naoaki, Fukunaga Atsushi, Kunimoto Hideo, Iwashita Hideyuki, Takata Kazuhide, Tanaka Takashi, Sakurai Kunitoshi, Inomata Shinjiro, Yokoyama Keiji, Nishizawa Shinya, Takeyama Yasuaki, Irie Makoto, Shakado Satoshi, Sohda Tetsuro, Sakisaka Shota |
| Prediction of features of the course of chronic hepatitis C using Bayesian networks. Terapevticheskii arkhiv 2019 Mar 91 (2): 32-39. Samokhodskaya L M, Starostina E E, Sulimov A V, Krasnova ? N, Rosina T P, Avdeev V G, Savkin I A, Sulimov V B, Mukhin N A, Tkachuk V A, Sadovnichii V |
| Association of IFNL3 rs12979860 polymorphism with HCV-related hepatocellular carcinoma susceptibility in a Chinese population. Clinical and experimental gastroenterology 2019 12 433-439. Hou Wei, Qiao Kunyan, Huo Zhixiao, Du Yanan, Wang Cindy, Syn Wing-K |
| Clinical Significance of Polymorphisms in Immune Response Genes in Hepatitis C-Related Hepatocellular Carcinoma. Frontiers in microbiology 2019 10 475. De Re Valli, Tornesello Maria Lina, De Zorzi Mariangela, Caggiari Laura, Pezzuto Francesca, Leone Patrizia, Racanelli Vito, Lauletta Gianfranco, Gragnani Laura, Buonadonna Angela, Vaccher Emanuela, Zignego Anna Linda, Steffan Agostino, Buonaguro Franco |
| Genetic associations of vitamin D receptor polymorphisms with advanced liver fibrosis and response to pegylated interferon-based therapy in chronic hepatitis C. PeerJ 2019 7 e7666. Thanapirom Kessarin, Suksawatamnuay Sirinporn, Sukeepaisarnjaroen Wattana, Tangkijvanich Pisit, Thaimai Panarat, Wasitthankasem Rujipat, Poovorawan Yong, Komolmit Piyaw |
| The interleukin 28B gene polymorphism, rs8099917, in patients with chronic hepatitis C and response to the treatment with pegylated interferon and ribavirin. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 2019 24 12. Kalantari Hamid, Bagherpour Bahram, Tavakoli Tahmine, Khodadoostan Mahsa, Hejazi Seyed Mehdi, Saadatmand Alire |
| High spontaneous clearance of symptomatic iatrogenic acute hepatitis C genotype 4 infection. Journal of medical virology 2018 Dec 90 (12): 1841-1847. Hashem Mohamed, Zaghla Hassan, Zakaria Zainab, Allam Walaa R, Sameea Eman Abdel, Mikhail Nabiel N, Sobhy Maha, Galal Iman F, Mokhtar Yasser, Hamdy Shimaa, Galal Gehan, Abdelwahab Sayed F, Waked Im |
| IL-28ß gene polymorphism determines virological response to PEGylated interferon therapy in hepatitis C virus genotype 4 Egyptian patients. Journal of cellular biochemistry 2018 Nov . El-Khazragy Nashwa, El Sayed Naglaa, Salem Ahmed M, Hassan Nahla S, Abdelmoeaz Amal Tohamy, Maher Amany M, Mansy Azza El-Say |
| IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4. British journal of biomedical science 2018 Jun . Attallah A M, Omran D, Marie M S, Abdelrazek M A, Salama A, El Essawey R, Mobarak L, Maklad S, Omar |
| No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B. PloS one 2018 13 (7): e0199198. Wei Lai, Wedemeyer Heiner, Liaw Yun-Fan, Chan Henry Lik-Yuen, Piratvisuth Teerha, Marcellin Patrick, Jia Jidong, Tan Deming, Chow Wan-Cheng, Brunetto Maurizia R, Diago Moisés, Gurel Selim, Morozov Viacheslav, He Hua, Zhu Yonghong, Wat Cynthia, Surujbally Bernadette, Thompson Alexander |
| Prevalence of hepatitis C virus infection and the IL28B genotype polymorphism among blood donors and high-risk populations. Singapore medical journal 2018 06 . Soh Benjy Yi-Min, Kumar Rajneesh, Ekstrom Victoria Sze-Min, Lin Clement Yi-Hao, Thangaraju Sobhana D/O, Tan Hwee Huang, Chan Kwai Peng, Choong Lina Hui Lin, Teo Diana, Chow Wan Che |
| [FREQUENCY OF OCCURRENCE OF POLYMORPHIC VARIANTS OF IL28B GENE AND GENOTYPES OF HEPATITIS C VIRUS IN POPULATION OF YAKUTIA: CLINICAL OUTCOMES]. Zhurnal mikrobiologii, epidemiologii, i immunobiologii 2017 Mar (2): 86-92. Semenov S I, Fedorov A L, Osakovsky V L, Maksimova S S, Platonov F |
| The Role of Biochemical Variations and Genotype Testing in Determining the Virological Response of Patients Infected with Hepatitis C Virus. Journal of global infectious diseases 0 10 (2): 89-98. Shoukat Abid, Khan Mosin S, Mudassar Syed, Kawoosa Zaffar, Shah Altaf H, Zargar Showkat A |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: